P atients with aneurysmal subarachnoid hemorrhage (SAH) who survive the initial bleed are subsequently at risk for several complications, particularly infarction and rebleeding.12 Early prediction of the risk for these complications would be important in the management of these patients and in the evaluation of new modes of treatment.
The Hunt and Hess (HH) classification, the Glasgow Coma Scale (GCS) score, and the grading scale of the World Federation of Neurosurgical Societies (WFNS) are clinical grading scales for recording the condition of SAH patients. [3] [4] [5] The initial score on these scales is strongly related to outcome. 1'46 None of these three clinical grading scales takes into account computed tomographic (CT) scan findings, in particular omitting the amount of extravasated blood. The total amount of subarachnoid blood on admission reflects the severity of the initial bleed and is a wellestablished predictor of infarction and outcome.7-10 In recent years we developed a grading scale for assessing the amount and distribution of cisternal and ventricular blood." In a previous series of patients this method proved to be useful.7"10'12 '13 In this study we compare and combine the three clinical scales with the CT findings, all obtained on the day of admission, to establish the additional value of the total amount of blood on the initial CT scan as a prognostic factor in a large series of patients with aneurysmal SAH.
Patients and Methods
From November 1977 to March 1989, we prospectively studied 649 consecutive patients admitted within 72 hours after the first symptoms and signs of SAH who had confirmatory evidence on the initial CT scan or, if the scan was negative, in the cerebrospinal fluid. Moribund patients were excluded. The patients were admitted to three neurological centers in The Netherlands and to two neurosurgical centers in Great Britain. The first 479 patients were part of a multicenter, randomized, double-blind, placebo-controlled trial aimed at determining the efficacy of a 4-week treatment (longterm) using the antifibrinolytic agent tranexamic acid. '4 The subsequent 120 patients were studied in a separate study involving a 4-day regimen (short-term) of tranexamic acid. 15 The last 50 patients were studied to estab- CT scanning was performed on admission and was repeated after any deterioration. The amount of intraventricular blood on the CT scans was graded for each of the four ventricles on a scale of 0 (no blood) to 3 (completely filled with blood); a sum score was obtained by summation of each ventricle score (0-12 points). The amount of cisternal blood on the CT scans was similarly graded from 0 to 3 points for 10 basal cisterns and fissures. The sum score was again obtained by summation of each cisternal score (0-30 points). This method has been previously described in detail." Intracerebral hematoma was graded as present or absent. Acute hydrocephalus was defined as a bicaudate index on the initial CT scan that exceeded the normal upper limit (95th percentile) for age. 13 The CT scans were graded by a single observer (P.J.A.M.B.) who was blinded to the clinical findings.
All clinical and outcome characteristics were recorded on case record forms. For the purpose of analysis, all these variables were dichotomized, with the median value as the cutoff point whenever appropriate; otherwise, we used absent/present or normal/abnormal scores. The clinical grading scales were analyzed as continuous variables.
Infarction and rebleeding were strictly defined according to previously described criteria.14 Outcome was assessed at 3 months by means of the five-point Glasgow Outcome Scale. 18 We dichotomized the grades of outcome on this scale as poor outcome (death, persistent vegetative state, or severely disabled) or good outcome (moderately disabled or good recovery).
Contingency tables were analyzed with two-sided x2 tests (p<0.05). The risk ratio and corresponding 95% confidence interval were chosen to express and analyze the determinant-outcome relationship.19,20 For the analysis of combinations of entry variables, we used logistic regression with step-wise forward selection. The logistic regression models were used to estimate the relative (odds ratio) and absolute risks associated with each determinant, adjusted for the influence of other determinants. The statistical significance of the regression models was determined by a standard likelihood ratio test.21 The predictive power of a model is largely determined by calibration (the trustworthiness of the exact values of the probabilities generated by the model) and discrimination (the extremeness of the probabilities generated by the model; i.e., an estimate of 0 or 1 gives far more guidance than an estimate of 0.5, however well calibrated).22.23 The calibration was assessed by comparing observed and expected frequencies,7 and the discriminatory ability was assessed by a quadratic score. This quadratic score is the average of the squared difference between the estimated probability of an outcome variable and the best bet (i.e., 0 or 1) of all patients.
Results Table 1 shows the relation between consecutive subseries, treatment protocols, and country of residence on the one hand and the occurrence of infarction, rebleeding, and poor outcome on the other. Patients on tranexamic acid suffered an episode of infarction more often, but the effect on outcome was balanced by a reduction of the rebleeding rate.14 Fluid restriction (in (Table 2) .
The upper part of Table 3 shows the risk ratios for the clinical baseline characteristics with regard to infarction, rebleeding, and poor outcome. There was a significant relation between a history of cardiovascular disease and cerebral infarction. The risk of rebleeding was significantly higher in patients aged over 52 years, patients with a history of hypertension, and in those with loss of consciousness at ictus. Poor outcome after 3 months was significantly related to all clinical characteristics listed in Table 3 , except admission to the hospital within 48 hours.
The CT characteristics on admission and the corresponding risk ratios for infarction, rebleeding, and poor outcome are listed in the lower part of There is an obvious interdependence between most of the variables in Tables 1-3 . To evaluate the independent predictive value of all these factors, we performed logistic regression with step-wise forward selection of variables. In the step-wise analysis with poor outcome as the dependent variable, female gender emerged as the least significant predictor (p=0.027); since we considered this an incidental finding it was omitted from the final model. The final models are presented in Table 4 . The risk of poor outcome was highest in patients with a decreased level of consciousness, who were treated with fluid restriction, who were older than 52 years, who had loss of consciousness at ictus, or who had a large amount of subarachnoid blood on the initial CT scan (>14). Infarction was significantly more common in patients with large amounts of subarachnoid blood on the initial scan or in those who were treated with tranexamic acid. The risk of rebleeding was significantly increased in patients who were not treated with tranexamic acid, who were older than 52 years, who had lost consciousness at ictus, or who were admitted to a neurology service rather than a neurosurgery service.
To explore how well the regression model for poor outcome fitted the observed data, we calculated the risk of poor outcome for each patient and ranked them Table 5 shows similar calculations after the amount of subarachnoid blood had been omitted from the regression model for poor outcome. The model remained highly statistically significant, and the predictive power barely changed.
In Table 6 the same method is applied to determine the additional value of the amount of subarachnoid blood for the prediction of infarction. In the upper part of Table 6 the complete model was used (Table 4 ) and in the lower part of Table 6 the amount of subarachnoid blood was omitted from the model. Including the amount of subarachnoid blood in the model considerably improved the statistical significance and predictive power of the model for infarction. Discussion A large amount of subarachnoid blood on the admission CT scan has considerable and independent predictive value for the occurrence of delayed cerebral infarction. For poor outcome, however, the predictive value of extravasated blood was rather modest.
The almost 500 patients in this study were treated in five centers in two countries over a period of 11 years. A reanalysis of three consecutive but separate series of patients, this time to assess the additional value of the amount of extravasated blood on the admission CT scan, has some drawbacks. However, all 471 patients were prospectively studied, and the entry criteria, the assessment of clinical deterioration, and the rating of outcome did not change over the years.'0,14,15 By means of the logistic regression analysis we tried to adjust for any influence of referral policy (interval between initial symptoms and admission, time of initial CT scan, and country, i.e., neurology versus neurosurgery services), known treatment policy at that time (fluid restriction and tranexamic acid treatment), or more subtle changes over the years, such as improvement of CT quality (study/time), on the occurrence of secondary complications and overall outcome. Although unknown factors may have influenced outcome events over the years, we consider it unlikely that such factors have changed the relative value of clinical and radiological predictors.
Because of the interdependence between many of the baseline clinical and CT scan variables, we performed A large amount of blood on the initial CT scan proved an independent prognostic factor. In predicting poor outcome it adds little to the GCS score, age, and loss of consciousness at ictus. Apparently the severity of the initial hemorrhage is manifested in a parallel fashion in the GCS score on admission and in the amount of subarachnoid blood on the initial CT scan. In contrast, as a predictive factor for infarction, the amount of subarachnoid blood on the initial CT scan is an important factor and is, in fact, the only disease-related prognostic factor. This is in accordance with other reports8'26 and reflects the role of subarachnoid blood in the development of infarction. An important iatrogenic factor is treatment with tranexamic acid, though this treatment was given in a period when the efficacy of nimodipine,27 an adequate supply of fluids,24 and avoidance of antihypertensive treatment28 was less completely known. Apparently the presence of cisternal clots predisposes the patient to delayed cerebral ischemia not only indirectly, as a reflection of the severity of the initial hemorrhage, but also in a more direct fashion. These direct factors are incompletely understood, if only because the occurrence of ischemia is not related to the clearance rate of subarachnoid blood10 and because the site of the ischemic lesions often does not correspond with the distribution of subarachnoid blood.7"10
In conclusion, we think it is appropriate to take into account the amount of subarachnoid blood on the initial CT scan as well as the GCS score when prognosis is estimated in patients with an aneurysmal SAH, particQuadratic score=44% ularly when considering the risk of infarction. 
